Staphylococcal septicaemia in burns

Area of Science:

• Infectious Diseases
• Burn Care
• Microbiology

Background:

• Staphylococcal septicaemia poses a significant threat to burn patients.
• Burn wounds create a high-risk environment for bloodstream infections in immunocompromised individuals.

Purpose of the Study:

• To analyze the incidence, characteristics, and outcomes of staphylococcal septicaemia in burn patients.
• To identify risk factors and effective management strategies for staphylococcal infections in a burn unit.

Main Methods:

• Retrospective analysis of 1516 burn patients admitted between 1992 and 1998.
• Clinical and microbiological data collection, including blood cultures and organism identification (MRSA, MSSA, MRSE, MSSE).
• Evaluation of treatment protocols, including glycopeptide therapy and skin grafting, and their impact on mortality.

Main Results:

• Staphylococcal septicaemia occurred in 7.2% of patients, with Staphylococcus aureus being the most common pathogen (73.4%).
• Methicillin-resistant Staphylococcus aureus (MRSA) was the predominant strain, responsible for 65% of staphylococcal septicaemia cases.
• Early detection (within 48 hours) and glycopeptide therapy were associated with improved survival rates, while inhalation injury combined with septicaemia was invariably fatal.

Conclusions:

• Burn units experience a high incidence of staphylococcal septicaemia, especially MRSA.
• Prompt diagnosis, appropriate antibiotic therapy (e.g., vancomycin), nutritional support, and early wound management are crucial for reducing mortality.
• Inhalation injury significantly increases mortality risk in burn patients with septicaemia.